Showing results (1401-1410 of 4,521) with videos related to
Sort By:
Pageof 453
Future Oncology (London, England)|April 11, 2022
Plain language summary of publication: new information for the potential role of afatinib in treating people with NRG1 gene fusion-positive cancerJacques CadranelFuture Oncology (London, England)|March 31, 2022
Generalizability of ORIENT-11 trial results to a US standard-of-care cohort with advanced non-small-cell lung cancerMisako Nagasaka, Cliff Molife, Zhanglin Lin Cui, et al.Future Oncology (London, England)|September 26, 2018
Ponatinib in the treatment of chronic myeloid leukemia and philadelphia chromosome positive acute lymphoblastic leukemiaCarolina Pavlovsky, Onyee Chan, Chetasi Talati, et al.Future Oncology (London, England)|September 26, 2018
Treatment patterns and outcomes for patients with advanced melanoma in US oncology clinical practicesEric D Whitman, Frank Xiaoqing Liu, Xiting Cao, et al.Future Oncology (London, England)|September 29, 2018
Paclitaxel reversed trastuzumab resistance via regulating JUN in human gastric cancer cells identified by FAN analysisZhe Wang, Fei Zou, Yingying Tian, et al.Future Oncology (London, England)|September 11, 2018
BRAFi/MEKi in patients with metastatic melanoma: predictive factors of complete responseSimone Ribero, Ottavia Malavenda, Paolo Fava, et al.Future Oncology (London, England)|October 11, 2018
Hypersensitivity and infusion-site adverse events with intravenous fosaprepitant after anthracycline-containing chemotherapy: a retrospective studyRalph Boccia, Robert B Geller, Neil Clendeninn, et al.Future Oncology (London, England)|March 16, 2022
Radiomics of dual-energy computed tomography for predicting progression-free survival in patients with early glottic cancerWenfei Li, Huanlei Zhang, Lei Ren, et al.Future Oncology (London, England)|May 30, 2018
Lymph node ratio has prognostic value related to the number of positive lymph nodes in patients with vulvar cancerSan-Gang Wu, Wen-Wen Zhang, Feng-Yan Li, et al.Future Oncology (London, England)|August 23, 2006
Nelarabine: efficacy in the treatment of clinical malignanciesAndrew M Roecker, Jeffery C Allison, David F KisorPageof 453